ArticleJournal of advanced research2021

Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism.

Songsong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.